why choose us

First received: June 29, 2023

Clinical Trial: POC Study to Evaluate the Efficacy and Safety of ESK-001 in Patients With Active Intermediate, Posterior, or Pan NIU

Study Status: Completed

Recruit Status: RECRUITING

Condition: Uveitis Posterior Non-Infectious

Study Type: INTERVENTIONAL


Official Title: A Proof-of-Concept, Randomized, Double-Masked Study to Evaluate the Efficacy and Safety of ESK-001 in Patients With Active Noninfectious Intermediate, Posterior, or Panuveitis (OPTYK-1)

Brief Summary: This is a multi-center, randomized, double-masked, proof-of-concept study in patients with Active Noninfectious Intermediate, Posterior, or Panuveitis.

Read more